The intraoperative neuromonitoring market in US is poised to grow by USD 955.33 million during 2020-2024, progressing at a CAGR of over 10% during the forecast period. Request free sample pages
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200316005573/en/
Technavio has announced its latest US research report titled Intraoperative Neuromonitoring Market in US 2020-2024 (Graphic: Business Wire)
Read the 120-page report with TOC on "Intraoperative Neuromonitoring Market In US Analysis Report by Type (Insourced IONM and Outsourced IONM), Application (Orthopedic and neurosurgeries, Cardiovascular surgeries, ENT surgeries, and Other surgeries), Methodology (Evoked potential (EP) monitoring, Electroencephalogram (EEG), and Electromyography (EMG), End-user (Hospitals, Ambulatory surgical centers (ASG), and Other end-users), and the Segment Forecasts, 2020-2024".
https://www.technavio.com/report/intraoperative-neuromonitoring-market-in-us-industry-analysis
The market is driven by the increasing number of surgeries that require IONM. In addition, the rising adoption of remote IONM is anticipated to boost the growth of the intraoperative neuromonitoring market in the US.
The number of high-risk surgeries such as cardiovascular procedure, musculoskeletal, and spinal is increasing. Many people in the US, suffering from this condition experience severe long-term pain and disabilities. In addition, patients suffering from cervical or neck pain and lumbar or low back pain require medical attention. IONM are extensively used by surgeons because these medical conditions are often associated with neurological complications. For instance, surgeons use IONM while performing spine surgery because it allows the early identification of electrophysiologic changes. It is also used to identify hemodynamic and other abnormalities. Thus, the increasing number of surgeries that require IONM is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Intraoperative Neuromonitoring Companies in the US:
Accurate Neuromonitoring LLC
Accurate Neuromonitoring LLC operates the business under the Services segment. The company offers various services including motor strip mapping, cranial nerve monitoring, pedicle screw stimulations, and more. It also offers intraoperative neuromonitoring for performing neuro-surgical and other procedures.
Cadwell Industries Inc.
Cadwell Industries Inc. offers products through the following business units: EEG, EMG, IONM, Sleep, CADLINK, and Electrodes and accessories. The company offers Cascade IOMAX, Cascade PRO, Arc Alterna, and Arc Essentia.
Computational Diagnostics Inc.
Computational Diagnostics Inc. operates under various business segments, namely NeuroNet and Services. The company offers NeuroNet VII, NN600, and NN650. NN650 is a durable and easy to use IOM system, whereas, NN600 is a portable multi-modality capable system.
IntraNerve Neuroscience Holdings LC
IntraNerve Neuroscience Holdings LC offers products through the Services business segment. The company offers neuroscience services such as remote professional interpretation services, neurotelemetry/cEEG services, and intraoperative neuromonitoring services.
Medtronic Plc
Medtronic Plc offers products through the following business segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The company offers NIM-RESPONSE 3.0, BIS Complete 2-Channel Monitor, BIS Complete 4-Channel Monitor, and NIM-Neuro 3.0.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Intraoperative Neuromonitoring Market in US: Type Outlook (Revenue, USD Billion, 2020-2024)
Intraoperative Neuromonitoring Market in US: Application Outlook (Revenue, USD Billion, 2020-2024)
Intraoperative Neuromonitoring Market in US: Methodology Outlook (Revenue, USD Billion, 2020-2024)
Intraoperative Neuromonitoring Market in US: End-user Outlook (Revenue, USD Billion, 2020-2024)
Technavio's sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health Care Include:
Neurodiagnostic and Monitoring Devices Market Global Neurodiagnostic and Monitoring Devices Market by product (electroencephalograph (EEG) devices, intracranial pressure (ICP) devices, electromyography (EMG) devices, and others) and geography (Asia, Europe, North America, and ROW).
Diabetic Neuropathy Drugs Market Global Diabetic Neuropathy Drugs Market by action (calcium channel alpha-2-delta ligand, SNRIs and TCAs, and others) and geography (Asia, Europe, North America, and ROW).
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200316005573/en/
- An update on Axon Therapy: A treatment used to relieve chronic neuropathy pain - Veterans Affairs - December 6th, 2024
- Hypothyroidism: Can it cause peripheral neuropathy? - December 6th, 2024
- A Case of Severe Advanced Diabetic Cardiac Autonomic Neuropathy: Severe Orthostatic Hypotension Complicated With Episodes of Nocturnal Supine... - December 6th, 2024
- Peripheral neuropathy - Care at Mayo Clinic - November 27th, 2024
- Diabetic neuropathy - Symptoms & causes - Mayo Clinic - November 27th, 2024
- Peripheral nerve injuries - Symptoms and causes - Mayo Clinic - November 27th, 2024
- Autonomic neuropathy - Symptoms & causes - Mayo Clinic - November 27th, 2024
- FDA clears IND application for epigenetic regulator to treat idiopathic neuropathy pain - Healio - November 27th, 2024
- Sponsored: Relieve Your Neuropathy with Advanced Nerve And Health Center - KHOU.com - November 27th, 2024
- Diabetic Peripheral Neuropathy Market size in the 7MM was approximately USD 2,740 million in 2022, estimated DelveInsight - The Globe and Mail - November 27th, 2024
- Peripheral neuropathy: Causes, symptoms, treatment, and prevention - September 21st, 2024
- Sponsored: Say goodbye to neuropathy with help from NexGenEsis Healthcare - KHOU.com - September 21st, 2024
- Danish Study Reveals Connection Between Diabetic Neuropathy, Retinopathy, and Severe Periodontitis - Medical Dialogues - September 21st, 2024
- What Is Neuropathy? Symptoms, Causes, Diagnosis, Treatment And ... - Forbes - July 30th, 2024
- Neuropathy | Duke Health - October 16th, 2023
- Peripheral Neuropathy | University Hospitals - May 9th, 2023
- Cranial Neuropathies | University Hospitals - May 9th, 2023
- Treatment for Peripheral Neuropathy & Other Nerve Damage | University ... - May 9th, 2023
- Neuromuscular Disease | Facts About Neuromuscular Disorders, Symptoms ... - May 9th, 2023
- Patrick McIntyre MD, JD Doctor Profile & Reviews | University Hospitals - May 9th, 2023
- Peripheral Neuropathy: What It Is, Symptoms & Treatment - Cleveland Clinic - May 1st, 2023
- Peripheral Neuropathy | National Institute of Neurological Disorders ... - May 1st, 2023
- Ionis Pharmaceuticals - Eplontersen halted ATTRv-PN disease progression and improved neuropathy impairment and quality of life in Phase 3 study... - May 1st, 2023
- Successfully Treating Diabetic Neuropathy at Vero Neuropathy | Paid Content - Local 5 - weareiowa.com - May 1st, 2023
- Peripheral Neuropathy Treatment at Advanced Nerve and Health Center - WFAA.com - May 1st, 2023
- Different Types of Peripheral Neuropathy | Paid Content - Local 5 - weareiowa.com - February 24th, 2023
- Peripheral neuropathy: Symptoms, causes, and treatment - Medical News Today - February 24th, 2023
- Natural Treatments for Peripheral Neuropathy - Healthline - December 28th, 2022
- Diabetic neuropathy types: Symptoms tell the story - Mayo Clinic - December 28th, 2022
- Supplements for Neuropathy: Vitamins and More - Healthline - December 28th, 2022
- The Effectiveness of Topical Cannabidiol Oil in Symptomatic ... - PubMed - December 28th, 2022
- Autonomic neuropathy - Diagnosis and treatment - Mayo Clinic - December 28th, 2022
- Peripheral neuropathy - Causes - NHS - December 28th, 2022
- Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and ... - PubMed - December 28th, 2022
- What Is Auditory Neuropathy? Causes & Treatment | NIDCD - December 20th, 2022
- Vero Neuropathy and Their Patients Pain Free Success Stories | Paid Content - Local 5 - weareiowa.com - December 20th, 2022
- Neuropathy No More Reviews (Blue Heron Health News) Does It Work? - Outlook India - December 20th, 2022
- Neuropathy Pain Treatment Market Size to Grow by USD 3.81 Bn, Growing Focus on Emerging Economies to be a Key Trend - Technavio - Yahoo Finance - October 7th, 2022
- Pregabalin Market to Grow by USD 153.03 Mn from 2022 to 2026, Driven by Presence of Large Patient Pool Related To Neuropathic Pain - Technavio - Yahoo... - October 7th, 2022
- Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics... - October 7th, 2022
- Side effects that may arise during breast cancer treatment The Hamburg Reporter - Hamburg Reporter - October 7th, 2022
- Neuropathy & the Truth About Alternative Care - North Forty News - June 16th, 2022
- Chemotherapy-Induced Peripheral Neuropathy: The Invisible Side Effect - Curetoday.com - June 16th, 2022
- Thermal gradient ring reveals thermosensory changes in diabetic peripheral neuropathy in mice | Scientific Reports - Nature.com - June 16th, 2022
- GenSight Biologics Announces Participation and Presentation of GS010 Clinical Data at EUNOS 2022 - Business Wire - June 16th, 2022
- Warning Signs of Diabetes, Says Physician Eat This Not That - Eat This, Not That - June 16th, 2022
- Foot Disease: The Most Feared Of All The Consequences Of Diabetes - Pressat - June 16th, 2022
- How Mindfulness Meditation May Help Ease Stress and Anxiety in Cancer Survivors, and Where to Start - Curetoday.com - June 16th, 2022
- TYPES OF CANNABIS STRAINS AND THE TYPE OF PAIN THEY TREAT - GISuser.com - June 16th, 2022
- 5 Types of Neuropathy and What to Do About Them | Fort ... - April 26th, 2022
- Unilateral Compressive Optic Neuropathy As the Presenting Manifestation of Clival Chordoma: A Case Report - Cureus - April 26th, 2022
- A Case of Secondary Trigeminal Neuropathy Due to Local Malignant Invasion of the Maxillary and Mandibular Nerves at the Skull Base: A Case Report With... - April 26th, 2022
- Global Leber's Hereditary Optic Neuropathy Drug Market 2022 to 2031 Analysis themobility.club - themobility.club - April 26th, 2022
- Risks of vitamin B12 deficiency and the symptoms to look out for - My London - April 26th, 2022
- NeuraLace announces two new patents for Axon neuropathic pain therapies - NeuroNews International - April 26th, 2022
- Neuropathic pain Market Overview By Share, Size, Industry Players, Revenue and Product Demand 2021-2030 The New York Irish Emgirant - The New York... - April 26th, 2022
- Find Help For Peripheral Neuropathy With Corrective Health - KXAN.com - November 21st, 2021
- AlgoTherapeutix Completes Phase I for Peripheral Neuropathy Program ATX01, Poised for Phase II Initiation in 2022 - Business Wire - November 21st, 2021
- Diabetic Neuropathy Treatment Industry Growth Forecast Analysis Manufacturers, Regions, Type and Application to 2026 - Northwest Diamond Notes - November 21st, 2021
- Diabetes: The 'tingling' sensation that can be caused by long-term high blood sugar - Daily Express - November 21st, 2021
- Vaccinations urged against shingles, a viral infection that's on the rise - Yahoo News - November 21st, 2021
- Broadway Vascular Announces Top-Line Results of 12-Month Retrospective Analysis Evaluating Revascularization of the Lateral Plantar Artery in Diabetic... - October 26th, 2021
- Applied Therapeutics Reports Biomarker Data from Pilot Trial of AT-007 in SORD Deficiency - Yahoo Finance - October 26th, 2021
- Heres Why Alger Sold its Nevro Corp. (NVRO) Position - Yahoo Finance - October 26th, 2021
- Zika virus in UP: Symptoms, treatment and other things to know - Hindustan Times - October 26th, 2021
- Ask the GP: Why do my feet feel like they're on fire? - The Irish News - October 26th, 2021
- For veterans: VA prepares to tackle backlogged disability claims - The Herald-Times - October 26th, 2021
- Tri-State Neuropathy Centers continues to expand its peripheral neuropathy treatment practice in the tri-state area to continue its mission to help... - August 17th, 2021
- Out of Every Ten Diabetic Patient, At least Seven are Identified with Diabetic Neuropathy - BioSpace - August 17th, 2021
- CCM can identify nerve damage in patients with long COVID, new study finds - Mobihealth News - August 17th, 2021
- Spotlight on ultrasonography in the diagnosis of PND | IJGM - Dove Medical Press - August 17th, 2021
- Eye scan could determine whether COVID patients will be long haulers - WGNO New Orleans - August 17th, 2021
- Diabetic Neuropathy Treatment Market Trends and Forecast to 2027 Players are Abbott, Roche, Eli Lilly - The Manomet Current - August 17th, 2021
- The Feather and the Knife: Navigating Life With Chronic Pain - POZ - August 17th, 2021
- Taysha Gene Therapies Secures up to $100 Million Non-Dilutive Term Loan Financing - Yahoo Finance - August 17th, 2021
- Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings Update - Yahoo Finance - August 17th, 2021
- Ugly Side Effects of Too Many Vitamins - Eat This Not That - Eat This, Not That - August 17th, 2021
- Chemotherapy Induced Peripheral Neuropathy Pipeline Analysis Shows Tremendous Growth Opportunities for the Coming Years in the Domain - Digital... - May 14th, 2021
- Osmol Therapeutics Initiates IND Enabling Studies to Develop First Therapy for Prevention of Chemotherapy-Induced Peripheral Neuropathy - BioSpace - May 14th, 2021
- Global Chronic Pain associated with Painful Diabetic Neuropathy Market to 2025 - Insight, Competitive Landscape and Forecasts - ResearchAndMarkets.com... - May 14th, 2021